Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 21, Issue 4 SUPPL., 1999, Pages

  Jones, Jeffrey L ^a   Hanson, Debra L ^a   Dworkin, Mark S ^a   Ward, John W ^a   Jaffe, Harold W ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

AIDS; Epidemiology; HIV; Malignancy

Indexed keywords

ANTIVIRUS AGENT; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; BRAIN LYMPHOMA; BURKITT LYMPHOMA; CANCER INCIDENCE; CANCER RISK; CONFERENCE PAPER; DISEASE ASSOCIATION; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; BRAIN NEOPLASMS; BURKITT LYMPHOMA; DRUG THERAPY, COMBINATION; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; LYMPHOMA, AIDS-RELATED; LYMPHOMA, LYMPHOBLASTIC; LYMPHOMA, NON-HODGKIN; MALE; MULTICENTER STUDIES; NEOPLASMS; SARCOMA, KAPOSI; UTERINE CERVICAL NEOPLASMS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0033179297     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Centers for Disease Control and Prevention. Kaposi's sarcoma and pneumocystis pneumonia among homosexual men - New York City and California. MMWR Morbid Mortal Wkly Rep 1981;30: 305-8.
2. Biggar RJ, Horm J, Lubin JH, et al. Cancer trends in a population at risk of acquired immunodeficiency syndrome. J Natl Cancer Inst 1985;74:793-7.
3. Cote TR, Biggar RJ, Rosenberg PS, et al. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and pub-lic health burden. AIDS/Cancer Study Group, Int J Cancer 1997; 73:645-50.
4. Biggar RJ, Curtis RE, Cote TR, et al. Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome. Am J Epidemiol 1994;139:362-8.
5. Hessol NA, Katz MH, Liu JY, et al. Increased incidence of Hodgkin's disease in homosexual men with HIV infection. Ann Intern Med 1992;117:309-11.
6. Reynolds P, Saunders LD, Layefsky ME, et al. The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980-1987. Am J Epidemiol 1993;137: 19-30.
7. Biggar RJ, Rabkin CS. The epidemiology of AIDS-related neoplasms. Hematol Oncol Clin North Am 1996;10:997-1010.
8. Klevens RM, Fleming PL, Mays MA, Frey RF. Characteristics of women with AIDS and invasive cervical cancer. Obstet Gynecol 1996;88:269-73.
9. Graham NMH, Zeger SL, Park LP, et al. The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med 1992;326:1037-42.
10. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-33.
11. Centers for Disease Control and Prevention. Update: trends in AIDS incidence, deaths, and prevalence - United States, 1996. MMWR Morbid Mortal Wkly Rep 1997;46:165-73.
12. Centers for Disease Control and Prevention. Update: trends in AIDS incidence United States, 1996. MMWR Morbid Mortal Wkly Rep 1997;46:861-7.
13. Karon JM, Devine OJ, Morgan WM. Predicting AIDS incidence by extrapolation from recent trends. In: Castillo-Chavez C, ed. Mathematical and Statistical Approaches to AIDS Epidemiology: Lecture Notes in Biomathematics, vol. 83: Berlin: Springer-Verlag, 1989:58-88.
14. Green TA, Karon JM, Nwanyanwu OC. Changes in AIDS incidence trends in the United States. J Acquir Immune Defic Syndr 1992;547-55.
15. Karon JM, Green TA, Hanson DL, Ward JW. Estimating the number of AIDS-defining opportunistic illness diagnoses from data collected under the 1993 AIDS surveillance case definition. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:116-21.
16. Farizo KM, Buehler JW, Chamberland ME, et al. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992;267:1798-1805.
17. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morbid Mortal Wkly Rep 1992;41(RR-17):1-19.
18. Centers for Disease Control and Prevention. Report of the NIH panel to define principles of therapy of HIV infection and guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Morbid Mortal Wkly Rep 1998;(RR-5): 1-82.
19. Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
20. Jones JL, Hanson DL, Chu SY, Fleming PL, Hu DJ, Ward JW. Surveillance of AIDS-defming conditions in the United States. AIDS 1994;8:1489-93.
21. Rutherford GW, Schwarcz SK, Lemp GF, et al. The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco. J Infect Dis 1989;159:569-72.
22. Des Jarlais DC, Stoneburner R, Thomas P, et al. Declines in the proportion of Kaposi's sarcoma among cases of AIDS in multiple risk groups in New York City. Lancet 1987;2:1024-5.
23. Selik RM, Starcher SE, Curran JW. Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends. AIDS 1987;1:175-82.
24. Schwartlander B, Horsburgh CR, Hamouda O, Skarabis H, Koch MA. Changes in the spectrum of AIDS-defining conditions and decrease in CD4-lymphocyte counts at AIDS manifestation in Germany from 1986 to 1991. AIDS 1992;6:413-20.
25. Hermans P, Lundgren J, Sommereigns B, et al. Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS 1996;10:911-17.
26. Katz MN, Hessol NA, Buchbinder SP, Hirozawa A, O'Malley P, Holmberg SD. Temporal trends of opportunistic infections and malignancies in homosexual men with AIDS. J Infect Dis 1994; 170:198-202.
27. Jacobson LP, Munoz A, Fox R, et al. Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with the human immunodeficiency virus type 1. J Acqir Immune Defic Syndr 1990;3(Suppl 1):S24-S31.
28. Lundgren JD, Melbye M, Pedersen C, et al. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. The Danish Study Group for HIV Infection (DASHI). Am J Epidemiol 1995;141:652-8.
29. Selik RM, Chu SY, Ward JW. Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann Intern Med 1995;123:933-6.
30. Munoz A, Schrager LK, Bacellar H, et al. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the multicenter AIDS cohort study; 1985-1991. Am J Epidemiol 1993;137:423-8.
31. 3. J Infect Dis 1994:170;1284-7.
32. Lundgren JD, Melbye M, Pedersen C, Rosenberg PS, Gerstoft J for the Danish Study Group for HIV Infection. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. Am J Epidemiol 1995;141: 652-8.
33. Cote TR, Biggar RJ. Does zidovudine cause non-Hodgkin's lymphoma [letter]? AIDS 1995;9:404-5.